[Reversible demyelinisation of corpus callosum in the course of Marchiafava-Bignami disease]
- PMID: 16628513
[Reversible demyelinisation of corpus callosum in the course of Marchiafava-Bignami disease]
Abstract
Marchiafava-Bignami disease is a rare disorder of an unknown aetiology that is marked by focal demyelinisation in the corpus callosum. Chronic alcohol abuse plays an important role in its development. Its course is unfavourable, although rare cases of clinical improvement confirmed in MRI have been reported. Until now, no case of Marchiafava-Bignami disease diagnosed intra vitam was so far described on the territory of Poland. The authors present such a case with favourable course. A 52-year-old male with chronic alcoholism was hospitalised due to altered consciousness which developed subacutely prior to admission. The first MRI scans yielded demyelinating lesions in the corpus callosum. The clinical and radiological findings were consistent with the diagnosis of Marchiafava-Bignami disease. Thiamine, vitamin B12, folic acid and amantadine were administered, which resulted in an improvement in both motor and cognitive functions. Control MRI scans revealed remyelinisation of the corpus callosum. Hence, this technique proved itself to be useful in monitoring the course of the disease.
Similar articles
-
[Marchiafava-Bignami disease].Wiad Lek. 2006;59(7-8):563-7. Wiad Lek. 2006. PMID: 17209361 Polish.
-
Images in clinical medicine. Marchiafava-Bignami disease.N Engl J Med. 2004 Sep 9;351(11):e10. doi: 10.1056/NEJMicm030414. N Engl J Med. 2004. PMID: 15356319 No abstract available.
-
[A woman without speech].Ned Tijdschr Geneeskd. 2012;156(18):A3417. Ned Tijdschr Geneeskd. 2012. PMID: 22551754 Dutch.
-
[Marchiafava-Bignami disease].Rev Neurol. 1999 Mar 1-15;28(5):519-23. Rev Neurol. 1999. PMID: 10229969 Review. Spanish.
-
Acute Marchiafava-Bignami disease with extensive diffusion restriction and early recovery: case report and review of the literature.J Neuroimaging. 2014 Jul-Aug;24(4):421-4. doi: 10.1111/j.1552-6569.2012.00755.x. Epub 2012 Dec 17. J Neuroimaging. 2014. PMID: 23253188 Review.
Cited by
-
Amantadine as a Potential Treatment for Marchiafava-Bignami Disease: Case Reports and a Possible Mechanism.Case Rep Neurol Med. 2022 Apr 11;2022:4585206. doi: 10.1155/2022/4585206. eCollection 2022. Case Rep Neurol Med. 2022. PMID: 35444836 Free PMC article.
-
Marchiafava-Bignami disease in chronic alcoholic patient.Radiol Case Rep. 2016 Jul 9;11(3):234-7. doi: 10.1016/j.radcr.2016.05.015. eCollection 2016 Sep. Radiol Case Rep. 2016. PMID: 27594956 Free PMC article.
-
Overreligious beliefs with neuropsychiatric manifestations in a young lady-Rule out Marchiafava-Bignami disease.Med J Armed Forces India. 2019 Apr;75(2):228-231. doi: 10.1016/j.mjafi.2019.02.011. Epub 2019 Apr 15. Med J Armed Forces India. 2019. PMID: 31065197 Free PMC article.
-
Marchiafava-Bignami disease: a rare entity with a poor outcome.Rev Bras Ter Intensiva. 2013 Mar;25(1):68-72. doi: 10.1590/s0103-507x2013000100013. Rev Bras Ter Intensiva. 2013. PMID: 23887763 Free PMC article.
-
Clinico-radiologic subtypes and therapeutic observation of acute Marchiafava-Bignami disease.Sci Rep. 2023 Oct 28;13(1):18516. doi: 10.1038/s41598-023-45431-6. Sci Rep. 2023. PMID: 37898646 Free PMC article.